ResearcherLeiden University Medical CenterNo recent work listed
Tao Zhang
Matched on ORCID iD 0000-0003-0427-9953; OpenAlex author ID A5100375876. Sources: OpenAlex.
Their work
- Papers
- 2 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 6
2020: 1 paper · 2021: none · 2022: 1 paper
Papers 2
- Transforming growth factor-β challenge alters the N-, O-, and glycosphingolipid glycomes in PaTu-S pancreatic adenocarcinoma cells. Last author DOI 10.1016/j.jbc.2022.101717↗
- Differential O- and Glycosphingolipid Glycosylation in Human Pancreatic Adenocarcinoma Cells With Opposite Morphology and Metastatic Behavior. Co-author DOI 10.3389/fonc.2020.00732↗
Closest collaborators
The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jing Zhang · 2 shared papers, 2020–2022 · strength 0.28
- Paper Transforming growth factor-β challenge alters the N-, O-, and glycosphingolipid glycomes in PaTu-S pancreatic adenocarc… DOI 10.1016/j.jbc.2022.101717↗
- Paper Differential O- and Glycosphingolipid Glycosylation in Human Pancreatic Adenocarcinoma Cells With Opposite Morphology a… DOI 10.3389/fonc.2020.00732↗
- Manfred Wuhrer · 2 shared papers, 2020–2022 · strength 0.28
- Paper Transforming growth factor-β challenge alters the N-, O-, and glycosphingolipid glycomes in PaTu-S pancreatic adenocarc… DOI 10.1016/j.jbc.2022.101717↗
- Paper Differential O- and Glycosphingolipid Glycosylation in Human Pancreatic Adenocarcinoma Cells With Opposite Morphology a… DOI 10.3389/fonc.2020.00732↗
- Peter ten Dijke · 2 shared papers, 2020–2022 · strength 0.28
- Paper Transforming growth factor-β challenge alters the N-, O-, and glycosphingolipid glycomes in PaTu-S pancreatic adenocarc… DOI 10.1016/j.jbc.2022.101717↗
- Paper Differential O- and Glycosphingolipid Glycosylation in Human Pancreatic Adenocarcinoma Cells With Opposite Morphology a… DOI 10.3389/fonc.2020.00732↗
- Stephanie Holst · 1 shared paper, 2022 · strength 0.16
- Ana I. Belo · 1 shared paper, 2020 · strength 0.11
- Irma van Die · 1 shared paper, 2020 · strength 0.11
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.